| MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition D Horiuchi, L Kusdra, NE Huskey, S Chandriani, ME Lenburg, ... Journal of Experimental Medicine 209 (4), 679-696, 2012 | 401 | 2012 |
| Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis DJ DePianto, S Chandriani, AR Abbas, G Jia, EN N'Diaye, P Caplazi, ... Thorax 70 (1), 48-56, 2015 | 278 | 2015 |
| A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism MA Nikiforov, S Chandriani, B O'Connell, O Petrenko, I Kotenko, A Beavis, ... Molecular and cellular biology 22 (16), 5793-5800, 2002 | 237 | 2002 |
| TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins MA Nikiforov, S Chandriani, J Park, I Kotenko, D Matheos, A Johnsson, ... Molecular and cellular biology 22 (14), 5054-5063, 2002 | 175 | 2002 |
| Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis S Chandriani, P Skewes-Cox, W Zhong, DE Ganem, TJ Divers, ... Proceedings of the National Academy of Sciences 110 (15), E1407-E1415, 2013 | 171 | 2013 |
| A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response S Chandriani, E Frengen, VH Cowling, SA Pendergrass, CM Perou, ... PloS one 4 (8), e6693, 2009 | 169 | 2009 |
| A Conserved Myc Protein Domain, MBIV, Regulates DNA Binding, Apoptosis, Transformation, and G2 Arrest VH Cowling, S Chandriani, ML Whitfield, MD Cole Molecular and cellular biology 26 (11), 4226-4239, 2006 | 149 | 2006 |
| Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus S Chandriani, D Ganem Journal of virology 84 (11), 5565-5573, 2010 | 140 | 2010 |
| Activation of Rho-dependent cell spreading and focal adhesion biogenesis by the v-Crk adaptor protein ZF Altun-Gultekin, S Chandriani, C Bougeret, T Ishizaki, S Narumiya, ... Molecular and cellular biology 18 (5), 3044-3058, 1998 | 95 | 1998 |
| The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes S Chandriani, Y Xu, D Ganem Journal of virology 84 (16), 7934-7942, 2010 | 88 | 2010 |
| Endogenously expressed IL-13Rα2 attenuates IL-13–mediated responses but does not activate signaling in human lung fibroblasts S Chandriani, DJ DePianto, EN N’Diaye, AR Abbas, J Jackman, J Bevers, ... The Journal of Immunology 193 (1), 111-119, 2014 | 77 | 2014 |
| Host transcript accumulation during lytic KSHV infection reveals several classes of host responses S Chandriani, D Ganem PLoS One 2 (8), e811, 2007 | 62 | 2007 |
| CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis G Jia, S Chandriani, AR Abbas, DJ DePianto, EN N'Diaye, MB Yaylaoglu, ... Thorax 72 (9), 780-787, 2017 | 61 | 2017 |
| Characterization of glycan substrates accumulating in GM1 Gangliosidosis R Lawrence, JL Van Vleet, L Mangini, A Harris, N Martin, W Clark, ... Molecular Genetics and Metabolism Reports 21, 100524, 2019 | 29 | 2019 |
| Neurofilament light is a treatment‐responsive biomarker in CLN2 disease Y Ru, C Corado, RK Soon Jr, AC Melton, A Harris, GK Yu, N Pryer, ... Annals of Clinical and Translational Neurology 6 (12), 2437-2447, 2019 | 25 | 2019 |
| Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor MC Babcock, CR Mikulka, B Wang, S Chandriani, S Chandra, Y Xu, ... Scientific reports 11 (1), 14486, 2021 | 19 | 2021 |
| Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders JC Ullman, KT Mellem, Y Xi, V Ramanan, H Merritt, R Choy, T Gujral, ... Science Translational Medicine 16 (730), eadf1691, 2024 | 17 | 2024 |
| Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis AR Abbas, JR Arron, S Chandriani, G Jia, NJI Lewin-Koh, D DePianto US Patent App. 14/493,649, 2016 | 5 | 2016 |
| Pharmacology of small molecule inhibitors of GYS1 in a mouse model of Pompe disease Y Xi, TF Satterfield, R Choy, T Gujral, E Situ, S Tep, V Morton, C Yu, ... Molecular Genetics and Metabolism 135 (2), S128, 2022 | 2 | 2022 |
| Abstract S5-4: Synthetic-Lethality of Triple-Negative Breast Cancers Via the MYC Oncogene Pathway A Goga, D Horiuchi, L Kusdra, S Chandriani, ME Lenburg, ... Cancer Research 70 (24_Supplement), S5-4-S5-4, 2010 | 1 | 2010 |
